Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
About this item
Full title
Author / Creator
AMBITION Investigators , Galiè, Nazzareno , Barberà, Joan A , Frost, Adaani E , Ghofrani, Hossein-Ardeschir , Hoeper, Marius M , McLaughlin, Vallerie V , Peacock, Andrew J , Simonneau, Gérald , Vachiery, Jean-Luc , Grünig, Ekkehard , Oudiz, Ronald J , Vonk-Noordegraaf, Anton , White, R. James , Blair, Christiana , Gillies, Hunter , Miller, Karen L , Harris, Julia H.N , Langley, Jonathan and Rubin, Lewis J
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Patients with previously untreated pulmonary arterial hypertension who were randomly assigned to combination therapy with ambrisentan and tadalafil had a significantly lower risk of a composite clinical failure outcome at 20 months than did the pooled monotherapy group.
Regardless of the initiating trigger, pulmonary arterial hypertension result...
Alternative Titles
Full title
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Authors, Artists and Contributors
Author / Creator
Galiè, Nazzareno
Barberà, Joan A
Frost, Adaani E
Ghofrani, Hossein-Ardeschir
Hoeper, Marius M
McLaughlin, Vallerie V
Peacock, Andrew J
Simonneau, Gérald
Vachiery, Jean-Luc
Grünig, Ekkehard
Oudiz, Ronald J
Vonk-Noordegraaf, Anton
White, R. James
Blair, Christiana
Gillies, Hunter
Miller, Karen L
Harris, Julia H.N
Langley, Jonathan
Rubin, Lewis J
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_DiVA_org_liu_124285
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_liu_124285
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1413687
